Meet Our Team

Get to know the specialists behind inPhronesis

Our Story

inPhronesis was designed by CI consultants who needed to track large amounts of ever-changing data for multiple simultaneous clients and projects. Our team of experts truly understands what is needed in the Competitive and Business Intelligence world inside the Pharma and Biomedical industries, and we developed inVision as the solution.

What we do

inPhronesis offers clients a streamlined interface with custom functionality for their business intelligence. We configure enterprise level solutions that make our customers’ lives easier. inVision is the single tool that provides for quick collection and synthesis of everything needed to address the most important tactical and strategic questions.

Chris Martin, MBA, MS

President, Co-founder

Mr. Martin has over fourteen years of experience in healthcare industry consulting, finance, and healthcare policy. He previously served in health policy roles at the White House Office of Management and Budget. These roles included Medicare Desk Officer for the Office of Information and Regulatory Affairs, where he was responsible for providing recommendations to senior White House policy officials on healthcare policies and regulations.

Mr. Martin was the Vice President of Research at Lese Investments LLC, a healthcare focused investment company, and co-portfolio manager at Cameron Capital. He has also performed consulting in the healthcare industry at Biotech Tracker and McKinsey and Company. Mr. Martin has a Master in Business Administration from Harvard Business School, a Master in Engineering from Villanova University, and a Bachelor of Science, with distinction, in Mechanical Engineering from Cornell University

Ben Weintraub, PhD


After completing his training in immunology and biochemistry, Dr. Weintraub began work as a financial analyst in 2000. Collaborating with Dr. Henderson and Chris Martin, Dr. Weintraub co-founded BiotechTracker, an online tool for investors. In 2004, he became a licensed security analyst with Hibernia Southcoast Capital covering the biotechnology sector, and later performed the same role at Variant Research. In 2006, Dr. Weintraub joined Dr. Henderson and Dr. Zuckerman at Reuters Insight, providing analysis of drug development and trends in medicine to professional investors. Dr. Weintraub’s team moved to inThought in January 2009. Through a divestiture by Wolters Kluwer, inThought and Source Healthcare Analytics became part of Symphony Health Solutions, a healthcare information company. inThought Research LLC formed a stand-alone company in May 2014.

Prior to 2000, Dr. Weintraub was senior scientific editor for the biology research journals Cell and Molecular Cell. Dr. Weintraub performed biochemistry and immunology research at Stanford University and at the John Curtin School of Medical Research in Canberra, Australia. He earned his doctorate in Biology from the University of California, San Diego, and a Bachelor of Science in Life Science from the Massachusetts Institute of Technology.

Doug Foster

Chief Operating Officer

As COO of inPhronesis Doug is focused on enhancing inVision to make it a world class competitive intelligence platform. We are adding additional AI/ML functionality to accelerate content ingestion, tagging, and searching.

As Manager of Online Education at InterSystems Doug built a dedicated online learning team focused on developing technical training content on InterSystems products for employees, partners and customers. As Director of Global Learning Services at Boston Scientific, he led the learning work stream of HR Transformation and managed the newly created Global Learning Services team. 

As an MIT graduate Doug has worked with start-up’s, operated as an independent consultant and grown a services business. He has contributed on all sides of human capital and knowledge management and provide a specialized perspective characterized by a deep understanding of technology coupled with a unique ability to communicate with both technical professionals and business executives alike.

Jeff Wuchich

Vice President of Sales

Mr. Wuchich has over 25 years of experience in software sales. He has helped build out teams in large companies like IBM and SAS Institute, and has also helped start-up software companies rapidly capture market share through his own business.
Mr. Wuchich has personal experience with the challenges inPhronesis addresses through his experience as Co-Founder and Past-President of Cure AHC-Alternating Hemiplegia of Childhood. He is an active advocate for the Rare Disease community, often meeting with researchers, clinicians, members of Congress, the FDA, & NIH. Mr. Wuchich has a Bachelor of Arts in Psychology from the University of Chicago, a Master of Divinity from Asbury Theological Seminary, and a Master of Arts in Pastoral Counseling also from Asbury Theological Seminary.

Eric Tapley

Technology Director

Mr. Tapley is inPhronesis’s Information Technology Director and the lead architect and developer for the inVision system. Prior to joining inPhronesis, he spent over 15 years leading companies that worked with clients in healthcare, finance, and education. Eric Tapley received a BS in Social and Environmental Policy Analysis with System Dynamics from Worcester Polytechnic Institute (WPI) and holds certificates from Boston University in small business entrepreneurship.

Ben Schulkin

Director of Development

Ben Schulkin has a decade of experience as a software developer, web developer and account manager. As a web developer for 3000k, a leading web development company, he worked on large-scale systems and custom IT solutions for high-profile clients in the nonprofit, financial, legal and healthcare sectors. In 2008, he opened his own web consulting company, which in 2009 expanded into Red Sequoia, LLC.


inPhronesis, LLC
2411 Reading Drive
Orlando, FL  32804

Phronesis [ froh-nee-sis ] – an ancient Greek word for a type of wisdom or intelligence. More specifically, a type of wisdom relevant to practical action.